Stifel Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-6,436
| Closed | -$205K | – | 3423 |
|
|
2022
Q2 | $205K | Buy |
6,436
+323
| +5% | +$10.3K | ﹤0.01% | 2988 |
|
|
2022
Q1 | $211K | Sell |
6,113
-18,303
| -75% | -$632K | ﹤0.01% | 3098 |
|
|
2021
Q4 | $715K | Buy |
24,416
+2,517
| +11% | +$73.7K | ﹤0.01% | 2373 |
|
|
2021
Q3 | $558K | Buy |
21,899
+13,962
| +176% | +$356K | ﹤0.01% | 2519 |
|
|
2021
Q2 | $278K | Sell |
7,937
-651
| -8% | -$22.8K | ﹤0.01% | 2948 |
|
|
2021
Q1 | $350K | Buy |
8,588
+227
| +3% | +$9.25K | ﹤0.01% | 2695 |
|
|
2020
Q4 | $362K | Buy |
8,361
+1,633
| +24% | +$70.7K | ﹤0.01% | 2507 |
|
|
2020
Q3 | $371K | Sell |
6,728
-10,054
| -60% | -$554K | ﹤0.01% | 2271 |
|
|
2020
Q2 | $1.06M | Buy |
16,782
+1,466
| +10% | +$92.5K | ﹤0.01% | 1516 |
|
|
2020
Q1 | $779K | Sell |
15,316
-2,058
| -12% | -$105K | ﹤0.01% | 1587 |
|
|
2019
Q4 | $1.38M | Buy |
17,374
+4,206
| +32% | +$333K | ﹤0.01% | 1595 |
|
|
2019
Q3 | $629K | Buy |
13,168
+1,298
| +11% | +$62K | ﹤0.01% | 2036 |
|
|
2019
Q2 | $618K | Buy |
11,870
+419
| +4% | +$21.8K | ﹤0.01% | 2098 |
|
|
2019
Q1 | $599K | Buy |
11,451
+439
| +4% | +$23K | ﹤0.01% | 1963 |
|
|
2018
Q4 | $439K | Buy |
+11,012
| New | +$439K | ﹤0.01% | 2006 |
|